Well, It's August 13. US clinical trials website is still saying estimated completion for the CHF#2 trial as July 13, however the trial is still categorised as "ongoing".
http://clinicaltrials.gov/ct2/show/NCT00721045?term=revascor&rank=1
If MSB are as organised and thorough as made out you would think they would update this shortly as current status can't be correct (can't be complete in Juy 13 but ongoing in Aug 13?)
Wonder if they are hesitant to do this as sends signal of more delays? An update by way of market announcement would be nice? these Indian Whispers are getting old.
chf#2 study completion
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |